MXPA03011843A - Un nuevo receptor copulado a proteina g, gave3. - Google Patents
Un nuevo receptor copulado a proteina g, gave3.Info
- Publication number
- MXPA03011843A MXPA03011843A MXPA03011843A MXPA03011843A MXPA03011843A MX PA03011843 A MXPA03011843 A MX PA03011843A MX PA03011843 A MXPA03011843 A MX PA03011843A MX PA03011843 A MXPA03011843 A MX PA03011843A MX PA03011843 A MXPA03011843 A MX PA03011843A
- Authority
- MX
- Mexico
- Prior art keywords
- gave3
- novel
- proteins
- gave
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
Abstract
Se proporcionan nuevos polipeptidos de GAVE3, proteinas y moleculas de acido nucleico. Ademas de proteinas GAVE3 de longitud total aisladas, se dan a conocer proteinas de fusion de GAVE3 aisladas, peptidos antigenicos y anticuerpos anti-GAVE3. Se dan a conocer GAVE3, vectores de expresion recombinantes, celulas hospedadoras en las cuales se han introducido los vectores de expresion y animales no humanos transgenicos en los cuales se ha introducido o fragmentado un gen GAVE3. Se proporcionan tambien metodos de diag-nostico, de escrutinio y terapeuticos que utilizan composiciones de la invencion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/886,041 US20030059869A1 (en) | 2001-06-22 | 2001-06-22 | Novel G protein-coupled receptor, GAVE3 |
PCT/US2002/019490 WO2003000846A2 (en) | 2001-06-22 | 2002-06-21 | A novel g protein-coupled receptor, gave 3 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03011843A true MXPA03011843A (es) | 2004-03-26 |
Family
ID=25388250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03011843A MXPA03011843A (es) | 2001-06-22 | 2002-06-21 | Un nuevo receptor copulado a proteina g, gave3. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20030059869A1 (es) |
JP (1) | JP2005500036A (es) |
KR (1) | KR20040022432A (es) |
AR (1) | AR036104A1 (es) |
BR (1) | BR0210937A (es) |
CA (1) | CA2451686A1 (es) |
IL (1) | IL159477A0 (es) |
MX (1) | MXPA03011843A (es) |
NO (1) | NO20035670L (es) |
WO (1) | WO2003000846A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7993533B2 (en) * | 2006-09-29 | 2011-08-09 | Basf Se | Method for regenerating an auxiliary filtering agent |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001036473A2 (en) * | 1999-11-16 | 2001-05-25 | Pharmacia & Upjohn Company | Human g protein-coupled receptors |
-
2001
- 2001-06-22 US US09/886,041 patent/US20030059869A1/en not_active Abandoned
-
2002
- 2002-06-21 CA CA002451686A patent/CA2451686A1/en not_active Abandoned
- 2002-06-21 IL IL15947702A patent/IL159477A0/xx unknown
- 2002-06-21 KR KR10-2003-7016768A patent/KR20040022432A/ko not_active Application Discontinuation
- 2002-06-21 JP JP2003507233A patent/JP2005500036A/ja not_active Ceased
- 2002-06-21 MX MXPA03011843A patent/MXPA03011843A/es unknown
- 2002-06-21 WO PCT/US2002/019490 patent/WO2003000846A2/en not_active Application Discontinuation
- 2002-06-21 AR ARP020102346A patent/AR036104A1/es not_active Application Discontinuation
- 2002-06-21 BR BRPI0210937-9A patent/BR0210937A/pt unknown
-
2003
- 2003-12-18 NO NO20035670A patent/NO20035670L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20035670D0 (no) | 2003-12-18 |
AR036104A1 (es) | 2004-08-11 |
JP2005500036A (ja) | 2005-01-06 |
IL159477A0 (en) | 2004-06-01 |
WO2003000846A2 (en) | 2003-01-03 |
KR20040022432A (ko) | 2004-03-12 |
CA2451686A1 (en) | 2003-01-03 |
NO20035670L (no) | 2004-02-19 |
WO2003000846A3 (en) | 2004-03-04 |
BR0210937A (pt) | 2006-10-24 |
US20030059869A1 (en) | 2003-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999066025A3 (en) | Mtbx protein and nucleic acid molecules and uses therefor | |
DE60035517D1 (de) | Gl50 moleküle, sowie verwendungen derselben | |
NO20020861D0 (no) | PD-1, en reseptor for B7-4, og anvendelser derav | |
EP1009752A4 (en) | NOVEL TANGO-77 PROTEIN FAMILY MOLECULES AND USES THEREOF | |
WO2002070652A3 (en) | Novel molecules of the card-related protein family and uses thereof | |
AU3217100A (en) | Methods of use of a novel lysyl oxidase-related protein | |
WO2000052047A3 (en) | Human dickkopf-related protein and nucleic acid molecules and uses therefor | |
WO2002044354A3 (en) | Molecules of the card-related protein family and uses thereof | |
WO2001000826A3 (en) | Novel molecules of the card-related protein family and uses thereof | |
WO2000019988A8 (en) | NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF | |
EP1208196A4 (en) | NEW SECRETINE FAMILY GPCR TYPE 15571 MOLECULE AND USES THEREOF | |
WO2000012544A3 (en) | Novel irap-bp polypeptide and nucleic acid molecules and uses therefor | |
WO2002070657A3 (en) | 93870, a human g-protein coupled receptor and uses therefor | |
WO2001018216A3 (en) | 26176, a novel calpain protease and uses thereof | |
WO2002068591A3 (en) | G-protein coupled receptor nucleic acids, polypeptides, antibodies and uses thereof | |
WO2000008045A3 (en) | Novel molecules of the tango-93-related protein family and uses thereof | |
WO2002038767A3 (en) | G protein-coupled receptor protein and nucleic acid molecules and uses therefor | |
WO2001030971A3 (en) | Novel molecules and the card-related protein family and uses thereof | |
WO1999054437A3 (en) | Novel molecules of the t125-related protein family and uses thereof | |
WO2001077151A3 (en) | Fdrg proteins and nucleic acid molecules and uses therefor | |
WO2003029434A3 (en) | Novel molecules of the hkid-1-related protein family and uses thereof | |
WO2002085939A8 (en) | Novel molecules of the card-related protein family and uses thereof | |
MXPA03011843A (es) | Un nuevo receptor copulado a proteina g, gave3. | |
WO2001085768A3 (en) | G-protein coupled receptors and uses therefor | |
WO2003029413A3 (en) | A novel g protein-coupled receptor, gave 10 |